Canonical: https://ownershiptrace.com/13f/companies/6060

# Who owns Verrica Pharmaceuticals Inc. (VRCA)? Elite investor 13F holders

3 tracked elite investors reported holding Verrica Pharmaceuticals Inc as of 2026-06-30, including Caligan Partners, Cannell Capital, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Caligan Partners](https://ownershiptrace.com/13f/investors/125) | VERRICA PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5654329.00 USD | 923910.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1727492/0001420506-26-001809-index.html) |
| [Cannell Capital](https://ownershiptrace.com/13f/investors/132) | VERRICA PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-18 00:00:00 | 4797609.00 USD | 783923.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1058854/0001420506-26-001852-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | VERRICA PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | VERRICA PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 133226.00 USD | 21769.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)